The article discusses the adverse effects of the Trump Administration on bipartisan support for scientific research, highlighting the historical significance of government funding in promoting technological advancements. It underscores how such investments have laid the groundwork for America's strong economy, particularly through initiatives like the internet and the Human Genome Project. Additionally, it suggests that corporations benefiting from government research should pay royalties, benefiting taxpayers. Further, it critiques Carrie Battan's article for focusing on nicotine pouches without adequately addressing their appeal and risks to young users, suggesting a need for more rigorous scrutiny of harm-reduction narratives.
Dhruv Khullar writes astutely about how the Trump Administration has upended bipartisan support of scientific research, emphasizing the need for continued government-backed innovation.
The robust scientific and technological infrastructure of the U.S. is one of the reasons we have the strongest economy in the world.
In fact, if the goal of the Trump Administration is to save money, then it has things backward. Why not have corporations that benefit from government intellectual property pay royalties?
Carrie Battan's article on nicotine pouches and snus appears more like a soft endorsement than a discerning examination of the implications for young users.
Collection
[
|
...
]